Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.) Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment.
AsiaCardiovascular and respiratory healthChinaCongressional oversightDepartment of Health and Human ServicesDrug trafficking and controlled substancesGovernment employee pay, benefits, personnel managementGovernment ethics and transparency, public corruptionGovernment studies and investigationsHealth programs administration and fundingInfectious and parasitic diseasesMedical researchNational Institutes of Health (NIH)Public contracts and procurementResearch administration and fundingWorld health
FAUCI Act
USA117th CongressS-3159| Senate
| Updated: 11/3/2021
Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.) Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment.
AsiaCardiovascular and respiratory healthChinaCongressional oversightDepartment of Health and Human ServicesDrug trafficking and controlled substancesGovernment employee pay, benefits, personnel managementGovernment ethics and transparency, public corruptionGovernment studies and investigationsHealth programs administration and fundingInfectious and parasitic diseasesMedical researchNational Institutes of Health (NIH)Public contracts and procurementResearch administration and fundingWorld health